Ahad Eshraghian

About Ahad Eshraghian

Ahad Eshraghian, With an exceptional h-index of 26 and a recent h-index of 17 (since 2020), a distinguished researcher at Shiraz University of Medical Sciences, specializes in the field of Gastroenterology, Hepatology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination a Vascular Liver Disease Group (VALDIG) initiative

Practical guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

Angiotensin receptor blockers might be protective against hepatic steatosis after liver transplantation

Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: the impact on …

Early Liver Transplant In Patients With Liver Cirrhosis Recovered From COVID-19 Infection.

European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

Hepatic computed tomography volumetry for noninvasive detection of hepatic steatosis and steatohepatitis in living liver donors

Multifocal EBV-associated smooth muscle tumors in a patient with cytomegalovirus infection after liver transplantation: a case report from Shiraz, Iran

Ahad Eshraghian Information

University

Position

___

Citations(all)

2504

Citations(since 2020)

1507

Cited By

1475

hIndex(all)

26

hIndex(since 2020)

17

i10Index(all)

56

i10Index(since 2020)

38

Email

University Profile Page

Google Scholar

Ahad Eshraghian Skills & Research Interests

Gastroenterology

Hepatology

Top articles of Ahad Eshraghian

Extensive splanchnic vein thrombosis after SARS-CoV-2 vaccination a Vascular Liver Disease Group (VALDIG) initiative

Hepatology

2024/2/15

Ahad Eshraghian
Ahad Eshraghian

H-Index: 16

Practical guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

Clinical Nutrition

2023/4/10

Angiotensin receptor blockers might be protective against hepatic steatosis after liver transplantation

BMC gastroenterology

2023/5/15

Ahad Eshraghian
Ahad Eshraghian

H-Index: 16

Hamed Nikoupour
Hamed Nikoupour

H-Index: 5

Metabolic syndrome, hepatic fibrosis, and steatosis diagnosed by liver stiffness measurement and controlled attenuation parameter after liver transplantation: the impact on …

2022/10/3

Early Liver Transplant In Patients With Liver Cirrhosis Recovered From COVID-19 Infection.

Exp Clin Transplant

2022/10/1

European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

Clinical Nutrition

2022/10/1

Hepatic computed tomography volumetry for noninvasive detection of hepatic steatosis and steatohepatitis in living liver donors

Exp Clin Transplant

2022/4/1

Ahad Eshraghian
Ahad Eshraghian

H-Index: 16

Kourosh Kazemi
Kourosh Kazemi

H-Index: 12

Multifocal EBV-associated smooth muscle tumors in a patient with cytomegalovirus infection after liver transplantation: a case report from Shiraz, Iran

Diagnostic Pathology

2022/1/7

Variations in TM6SF2, PCSK9 and PCSK7 genes and risk of hepatic steatosis after liver transplantation: a cross-sectional study

BMC gastroenterology

2021/12

Noninvasive Estimation of Hepatic Steatosis by Controlled Attenuation Parameter in Living Donor Liver Transplant.

Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation

2021/9/20

Liver transplantation with simultaneous resection of primary tumor site for the treatment of neuroendocrine tumors with diffuse liver metastasis

Journal of Gastrointestinal Cancer

2021/6

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study

Journal of hepatology

2021/3/1

Outcomes of patients with decompensated cirrhosis and coronavirus disease 19: Mortality and safety of liver transplantation

United European Gastroenterology Journal

2021

LIVER TRANSPLANTATION IN PATIENTS WITH LIVER CIRRHOSIS RECOVERED FROM COVID-19 INFECTION

Transplant International

2021

Assessment of hydrogeochemical characteristics and quality of groundwater resources in relation to risk of gastric cancer: Comparative analysis of high-and low-risk areas in Iran

Water

2023/5/9

Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak

The Lancet Gastroenterology & Hepatology

2020/9/1

Ahad Eshraghian
Ahad Eshraghian

H-Index: 16

Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: the impact of uric acid

Clinics and Research in Hepatology and Gastroenterology

2020/9/1

Ahad Eshraghian
Ahad Eshraghian

H-Index: 16

Kourosh Kazemi
Kourosh Kazemi

H-Index: 12

Hepatic steatosis and liver fat contents in liver transplant recipients are associated with serum adipokines and insulin resistance

Scientific Reports

2020/7/29

Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis

HPB

2020/4/1

Ahad Eshraghian
Ahad Eshraghian

H-Index: 16

Kourosh Kazemi
Kourosh Kazemi

H-Index: 12

See List of Professors in Ahad Eshraghian University(Shiraz University of Medical Sciences)